Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Terbinafine HCl

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Terbinafine HCl Manufacturers in India Suppliers Terbinafine HCl Dossage Exporters Distributors Terbinafine HCl api active pharmaceuticals ingredients Terbinafine HCl manufacturers Side Effects bulk drugs raw material Dossage Terbinafine HCl companies Side Effects Dossage Importers Terbinafine HCl Dossage Terbinafine HCl Exporters Terbinafine HCl exporters Dossage FDA Dossage Terbinafine HCl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Terbinafine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Terbinafine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Terbinafine Hydrochloride active pharmaceutical ingredients Terbinafine Hydrochloride committee active pharmaceutical ingredients manufacturer Terbinafine Hydrochloride Active Pharmaceutical Ingredients manufacturer Terbinafine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Terbinafine HCl, Terbinafine HCl manufacturer India, Terbinafine HCl product, Terbinafine HCl products, Api preparation, Certificate of Analysis API manufacturer product, Terbinafine HCl anti ulcer product, Certificate of Origin COA Terbinafine HCl COS Terbinafine HCl, pharmaceutical generic, pharmaceutical drug, medical, Terbinafine HCl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Terbinafine HCl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Terbinafine HCl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Terbinafine HCl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Terbinafine HCl ingredients, api, HIV Terbinafine HCl, tablets, capsules, syrup & protein Terbinafine HCl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Terbinafine HCl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Terbinafine HCl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

CAPSUL









 







 

 

HOME >> Pharmaceuticals API List 3 >> Terbinafine Hcl >> Dosage

Terbinafine HCl CAS number 78628-80-5

DOSAGE
Terbinafine HCl
CAS number 78628-80-5

Terbinafine Hydrochloride should be taken once daily for 6 weeks by patients with fingernail onychomycosis. Terbinafine HCl should be taken once daily for 12 weeks by patients with toenail onychomycosis.

The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.

Those with reduced liver or kidney function may need an adjustment to the dose. The length of treatment depends on the condition being treated and the severity of the infection.

T
ake Terbinafine  250 mg once daily, preferably at the same time each day.

Take this Terbinafine HCl by mouth, usually once a day, or as directed by your doctor.

It may be taken with or without food. Dosage and duration of therapy is based on your medical condition and response to therapy. It may take several months after completion of treatment to see the full benefit of this drug.

 It takes time for your new healthy nails to grow out and replace the infected nails. Continue to take this medication until the full prescribed amount is finished. Stopping the medication too early may allow the fungus to continue to grow, which may result in a relapse of the infection.

 Inform your doctor if your condition persists or worsens.
 

Information Associated with Product:
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Terbinafine HCl

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.